Spatially Separate Docking Sites on ERK2 Regulate Distinct Signaling Events In Vivo
Open Access
- 1 July 2005
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 15 (14), 1319-1324
- https://doi.org/10.1016/j.cub.2005.06.037
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (GM51405, RO1CA46595)
- American Cancer Society
- Leukemia and Lymphoma Society
This publication has 24 references indexed in Scilit:
- Live Cell Imaging of ERK and MEKJournal of Biological Chemistry, 2005
- A Network of Immediate Early Gene Products Propagates Subtle Differences in Mitogen-Activated Protein Kinase Signal Amplitude and DurationMolecular and Cellular Biology, 2004
- CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)Seminars in Oncology, 2003
- Assembly of Cell Regulatory Systems Through Protein Interaction DomainsScience, 2003
- Molecular interpretation of ERK signal duration by immediate early gene productsNature Cell Biology, 2002
- Identification of Novel Point Mutations in ERK2 That Selectively Disrupt Binding to MEK1Journal of Biological Chemistry, 2002
- Evidence for Existence of a Nuclear Pore Complex-mediated, Cytosol-independent Pathway of Nuclear Translocation of ERK MAP Kinase in Permeabilized CellsJournal of Biological Chemistry, 2001
- Docking Sites on Substrate Proteins Direct Extracellular Signal-regulated Kinase to Phosphorylate Specific ResiduesJournal of Biological Chemistry, 2001
- Activation Mechanism of the MAP Kinase ERK2 by Dual PhosphorylationCell, 1997
- Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive SrcNature, 1995